Epilepsy Impact Scale
Questionnaire Development for a Comprehensive Scale to Measure the Impact of Epilepsy on Life.
1 other identifier
observational
51
1 country
1
Brief Summary
The investigators are developing a questionnaire that can quickly measure the impact that epilepsy has on a person's life. This questionnaire will be useful in following whether the impact of epilepsy increases, decreases or stays the same over time. The results also may point out areas that would benefit from discussion or attention in visits with your doctor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 29, 2013
CompletedFirst Posted
Study publicly available on registry
April 16, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedApril 13, 2016
April 1, 2016
2.2 years
March 29, 2013
April 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validation of a concise question set
Up to 1 year for question set validation, data presentation within up to 1.5 years
Secondary Outcomes (1)
Correlation of subscales
Up to 1.5 years
Study Arms (1)
People with epilepsy
People with epilepsy who have have had at least one seizure in the prior year.
Interventions
Eligibility Criteria
Patients in the Stanford Epilepsy Center who have had a seizure in the past year and agree to participate.
You may qualify if:
- Age 18 or more.
- Patient has had at least 1 seizure in the past 365 days.
- Patient can speak and understand English.
You may not qualify if:
- Patients suspected of having one of the imitators of epilepsy, for example, syncope, sleep disorder, psychogenic nonepileptic seizures, will be excluded, even if they also have epileptic seizures.
- Patients unwilling to spend the time doing the questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Stanford, California, 94305-5235, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert S Fisher, MD, PhD
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Neurology
Study Record Dates
First Submitted
March 29, 2013
First Posted
April 16, 2013
Study Start
July 1, 2012
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
April 13, 2016
Record last verified: 2016-04